25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Palatin Technologies Inc
Buy, Hold or Sell?

Let's analyze Palatin together

I guess you are interested in Palatin Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Palatin Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Palatin Technologies Inc

I send you an email if I find something interesting about Palatin Technologies Inc.

1. Quick Overview

1.1. Quick analysis of Palatin (30 sec.)










1.2. What can you expect buying and holding a share of Palatin? (30 sec.)

How much money do you get?

How much money do you get?
$0.03
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$-3.32
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-3.30
Return On Investment
-375.1%

For what price can you sell your share?

Current Price per Share
$0.88
Expected price per share
$0.68 - $1.7
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Palatin (5 min.)




Live pricePrice per Share (EOD)
$0.88
Intrinsic Value Per Share
$-54.95 - $-8.82
Total Value Per Share
$-54.94 - $-8.82

2.2. Growth of Palatin (5 min.)




Is Palatin growing?

Current yearPrevious yearGrowGrow %
How rich?$134k$16.2m-$16.1m-12,033.6%

How much money is Palatin making?

Current yearPrevious yearGrowGrow %
Making money-$27.5m-$35.8m$8.2m30.0%
Net Profit Margin-567.4%-2,438.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Palatin (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#813 / 961

Most Revenue
#356 / 961

Most Profit
#754 / 961

Most Efficient
#663 / 961
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Palatin?

Welcome investor! Palatin's management wants to use your money to grow the business. In return you get a share of Palatin.

First you should know what it really means to hold a share of Palatin. And how you can make/lose money.

Speculation

The Price per Share of Palatin is $0.8801. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Palatin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Palatin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $-0.83 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Palatin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.42-161.6%-1.42-161.6%-1.87-212.3%-0.87-98.5%-0.80-91.5%
Usd Book Value Change Per Share-0.83-94.6%-0.83-94.6%-1.72-195.8%-0.28-31.5%-0.12-13.4%
Usd Dividend Per Share0.010.9%0.010.9%0.011.3%0.033.6%0.021.8%
Usd Total Gains Per Share-0.83-93.8%-0.83-93.8%-1.71-194.5%-0.25-27.9%-0.10-11.6%
Usd Price Per Share2.10-2.10-0.28-0.93-0.84-
Price to Earnings Ratio-1.48--1.48--0.15--0.36--0.42-
Price-to-Total Gains Ratio-2.54--2.54--0.16--0.67-0.33-
Price to Book Ratio303.39-303.39-0.33-60.86-30.63-
Price-to-Total Gains Ratio-2.54--2.54--0.16--0.67-0.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8801
Number of shares1136
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.03
Usd Book Value Change Per Share-0.83-0.28
Usd Total Gains Per Share-0.83-0.25
Gains per Quarter (1136 shares)-937.64-279.17
Gains per Year (1136 shares)-3,750.58-1,116.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
134-3785-3761142-1259-1127
269-7570-7512284-2518-2244
3103-11355-11263427-3777-3361
4137-15139-15014569-5035-4478
5171-18924-18765711-6294-5595
6206-22709-22516853-7553-6712
7240-26494-26267995-8812-7829
8274-30279-300181138-10071-8946
9308-34064-337691280-11330-10063
10343-37848-375201422-12589-11180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%2.08.00.020.0%2.026.00.07.1%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%15.013.00.053.6%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%4.00.06.040.0%4.00.024.014.3%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%15.013.00.053.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Palatin Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.833-0.8330%-1.723+107%-0.277-67%-0.118-86%
Book Value Per Share--0.0070.0070%0.840-99%2.548-100%1.409-100%
Current Ratio--1.0791.0790%2.128-49%11.141-90%6.951-84%
Debt To Asset Ratio--0.9930.9930%0.549+81%0.380+161%0.670+48%
Debt To Equity Ratio--132.804132.8040%1.217+10810%26.896+394%13.662+872%
Dividend Per Share--0.0080.0080%0.011-34%0.031-76%0.016-52%
Eps---1.422-1.4220%-1.869+31%-0.867-39%-0.805-43%
Free Cash Flow Per Share---1.490-1.4900%-1.558+5%-0.643-57%-0.623-58%
Free Cash Flow To Equity Per Share---0.979-0.9790%-1.557+59%-0.279-71%-0.069-93%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.824--------
Intrinsic Value_10Y_min---54.946--------
Intrinsic Value_1Y_max---0.681--------
Intrinsic Value_1Y_min---2.465--------
Intrinsic Value_3Y_max---2.202--------
Intrinsic Value_3Y_min---10.083--------
Intrinsic Value_5Y_max---3.908--------
Intrinsic Value_5Y_min---20.578--------
Market Cap17047448.990-139%40676790.00040676790.0000%5435193.940+648%18062819.148+125%16239336.762+150%
Net Profit Margin---5.674-5.6740%-24.385+330%-8.234+45%-4.246-25%
Operating Margin---6.687-6.6870%-24.916+273%-13.362+100%-6.800+2%
Operating Ratio--7.8997.8990%25.916-70%38.521-79%20.019-61%
Pb Ratio127.151-139%303.393303.3930%0.334+90707%60.862+398%30.628+891%
Pe Ratio-0.619+58%-1.477-1.4770%-0.150-90%-0.359-76%-0.418-72%
Price Per Share0.880-139%2.1002.1000%0.281+648%0.933+125%0.838+150%
Price To Free Cash Flow Ratio-0.591+58%-1.410-1.4100%-0.180-87%-0.580-59%0.589-339%
Price To Total Gains Ratio-1.066+58%-2.544-2.5440%-0.164-94%-0.669-74%0.330-870%
Quick Ratio--1.1161.1160%1.951-43%10.964-90%6.825-84%
Return On Assets---1.535-1.5350%-0.993-35%-0.590-62%-0.894-42%
Return On Equity---205.425-205.4250%-2.201-99%-41.645-80%-21.018-90%
Total Gains Per Share---0.825-0.8250%-1.712+107%-0.246-70%-0.102-88%
Usd Book Value--134073.000134073.0000%16267875.000-99%49355082.600-100%27298300.200-100%
Usd Book Value Change Per Share---0.833-0.8330%-1.723+107%-0.277-67%-0.118-86%
Usd Book Value Per Share--0.0070.0070%0.840-99%2.548-100%1.409-100%
Usd Dividend Per Share--0.0080.0080%0.011-34%0.031-76%0.016-52%
Usd Eps---1.422-1.4220%-1.869+31%-0.867-39%-0.805-43%
Usd Free Cash Flow---28852928.000-28852928.0000%-30184123.000+5%-12449241.800-57%-12077087.900-58%
Usd Free Cash Flow Per Share---1.490-1.4900%-1.558+5%-0.643-57%-0.623-58%
Usd Free Cash Flow To Equity Per Share---0.979-0.9790%-1.557+59%-0.279-71%-0.069-93%
Usd Market Cap17047448.990-139%40676790.00040676790.0000%5435193.940+648%18062819.148+125%16239336.762+150%
Usd Price Per Share0.880-139%2.1002.1000%0.281+648%0.933+125%0.838+150%
Usd Profit---27541887.000-27541887.0000%-35808150.000+30%-16705557.000-39%-15546339.700-44%
Usd Revenue--4853678.0004853678.0000%1468457.000+231%13310400.600-64%19136231.800-75%
Usd Total Gains Per Share---0.825-0.8250%-1.712+107%-0.246-70%-0.102-88%
 EOD+3 -5MRQTTM+0 -0YOY+21 -145Y+8 -2710Y+7 -28

3.3 Fundamental Score

Let's check the fundamental score of Palatin Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.619
Price to Book Ratio (EOD)Between0-1127.151
Net Profit Margin (MRQ)Greater than0-5.674
Operating Margin (MRQ)Greater than0-6.687
Quick Ratio (MRQ)Greater than11.116
Current Ratio (MRQ)Greater than11.079
Debt to Asset Ratio (MRQ)Less than10.993
Debt to Equity Ratio (MRQ)Less than1132.804
Return on Equity (MRQ)Greater than0.15-205.425
Return on Assets (MRQ)Greater than0.05-1.535
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Palatin Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.974
Ma 20Greater thanMa 501.020
Ma 50Greater thanMa 1001.293
Ma 100Greater thanMa 2001.565
OpenGreater thanClose0.873
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Palatin Technologies Inc

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Fundamental data was last updated by Penke on 2024-09-25 02:36:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Palatin earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • A Net Profit Margin of -567.4% means that $-5.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Palatin Technologies Inc:

  • The MRQ is -567.4%. The company is making a huge loss. -2
  • The TTM is -567.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-567.4%TTM-567.4%0.0%
TTM-567.4%YOY-2,438.5%+1,871.0%
TTM-567.4%5Y-823.4%+255.9%
5Y-823.4%10Y-424.6%-398.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-567.4%-118.4%-449.0%
TTM-567.4%-189.8%-377.6%
YOY-2,438.5%-206.6%-2,231.9%
5Y-823.4%-365.0%-458.4%
10Y-424.6%-471.8%+47.2%
4.3.1.2. Return on Assets

Shows how efficient Palatin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • -153.5% Return on Assets means that Palatin generated $-1.54 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Palatin Technologies Inc:

  • The MRQ is -153.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -153.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-153.5%TTM-153.5%0.0%
TTM-153.5%YOY-99.3%-54.3%
TTM-153.5%5Y-59.0%-94.6%
5Y-59.0%10Y-89.4%+30.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-153.5%-10.9%-142.6%
TTM-153.5%-11.7%-141.8%
YOY-99.3%-11.2%-88.1%
5Y-59.0%-12.8%-46.2%
10Y-89.4%-14.4%-75.0%
4.3.1.3. Return on Equity

Shows how efficient Palatin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • -20,542.5% Return on Equity means Palatin generated $-205.42 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Palatin Technologies Inc:

  • The MRQ is -20,542.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20,542.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20,542.5%TTM-20,542.5%0.0%
TTM-20,542.5%YOY-220.1%-20,322.3%
TTM-20,542.5%5Y-4,164.5%-16,378.0%
5Y-4,164.5%10Y-2,101.8%-2,062.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20,542.5%-14.2%-20,528.3%
TTM-20,542.5%-15.9%-20,526.6%
YOY-220.1%-13.6%-206.5%
5Y-4,164.5%-19.0%-4,145.5%
10Y-2,101.8%-19.5%-2,082.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Palatin Technologies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Palatin is operating .

  • Measures how much profit Palatin makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • An Operating Margin of -668.7% means the company generated $-6.69  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Palatin Technologies Inc:

  • The MRQ is -668.7%. The company is operating very inefficient. -2
  • The TTM is -668.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-668.7%TTM-668.7%0.0%
TTM-668.7%YOY-2,491.6%+1,822.9%
TTM-668.7%5Y-1,336.2%+667.5%
5Y-1,336.2%10Y-680.0%-656.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-668.7%-258.6%-410.1%
TTM-668.7%-292.1%-376.6%
YOY-2,491.6%-222.8%-2,268.8%
5Y-1,336.2%-386.0%-950.2%
10Y-680.0%-497.7%-182.3%
4.3.2.2. Operating Ratio

Measures how efficient Palatin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 7.90 means that the operating costs are $7.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Palatin Technologies Inc:

  • The MRQ is 7.899. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.899. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.899TTM7.8990.000
TTM7.899YOY25.916-18.017
TTM7.8995Y38.521-30.622
5Y38.52110Y20.019+18.502
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.8992.659+5.240
TTM7.8993.111+4.788
YOY25.9163.299+22.617
5Y38.5215.070+33.451
10Y20.0196.539+13.480
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Palatin Technologies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Palatin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.08 means the company has $1.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Palatin Technologies Inc:

  • The MRQ is 1.079. The company is just able to pay all its short-term debts.
  • The TTM is 1.079. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.079TTM1.0790.000
TTM1.079YOY2.128-1.049
TTM1.0795Y11.141-10.062
5Y11.14110Y6.951+4.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0793.788-2.709
TTM1.0794.004-2.925
YOY2.1284.740-2.612
5Y11.1415.970+5.171
10Y6.9516.324+0.627
4.4.3.2. Quick Ratio

Measures if Palatin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • A Quick Ratio of 1.12 means the company can pay off $1.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Palatin Technologies Inc:

  • The MRQ is 1.116. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.116. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.116TTM1.1160.000
TTM1.116YOY1.951-0.835
TTM1.1165Y10.964-9.848
5Y10.96410Y6.825+4.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1163.381-2.265
TTM1.1163.576-2.460
YOY1.9514.734-2.783
5Y10.9645.910+5.054
10Y6.8256.503+0.322
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Palatin Technologies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Palatin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Palatin to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.99 means that Palatin assets are financed with 99.3% credit (debt) and the remaining percentage (100% - 99.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Palatin Technologies Inc:

  • The MRQ is 0.993. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.993. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.993TTM0.9930.000
TTM0.993YOY0.549+0.444
TTM0.9935Y0.380+0.612
5Y0.38010Y0.670-0.290
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9930.341+0.652
TTM0.9930.343+0.650
YOY0.5490.309+0.240
5Y0.3800.366+0.014
10Y0.6700.382+0.288
4.5.4.2. Debt to Equity Ratio

Measures if Palatin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Palatin to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13,280.4% means that company has $132.80 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Palatin Technologies Inc:

  • The MRQ is 132.804. The company is unable to pay all its debts with equity. -1
  • The TTM is 132.804. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ132.804TTM132.8040.000
TTM132.804YOY1.217+131.586
TTM132.8045Y26.896+105.908
5Y26.89610Y13.662+13.233
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ132.8040.393+132.411
TTM132.8040.437+132.367
YOY1.2170.373+0.844
5Y26.8960.449+26.447
10Y13.6620.489+13.173
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Palatin generates.

  • Above 15 is considered overpriced but always compare Palatin to the Biotechnology industry mean.
  • A PE ratio of -1.48 means the investor is paying $-1.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Palatin Technologies Inc:

  • The EOD is -0.619. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.477. Based on the earnings, the company is expensive. -2
  • The TTM is -1.477. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.619MRQ-1.477+0.858
MRQ-1.477TTM-1.4770.000
TTM-1.477YOY-0.150-1.327
TTM-1.4775Y-0.359-1.118
5Y-0.35910Y-0.418+0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.619-2.243+1.624
MRQ-1.477-2.403+0.926
TTM-1.477-2.929+1.452
YOY-0.150-3.417+3.267
5Y-0.359-5.877+5.518
10Y-0.418-6.197+5.779
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Palatin Technologies Inc:

  • The EOD is -0.591. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.410. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.410. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.591MRQ-1.410+0.819
MRQ-1.410TTM-1.4100.000
TTM-1.410YOY-0.180-1.230
TTM-1.4105Y-0.580-0.830
5Y-0.58010Y0.589-1.169
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.591-2.930+2.339
MRQ-1.410-3.181+1.771
TTM-1.410-3.471+2.061
YOY-0.180-4.579+4.399
5Y-0.580-7.975+7.395
10Y0.589-8.636+9.225
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Palatin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 303.39 means the investor is paying $303.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Palatin Technologies Inc:

  • The EOD is 127.151. Based on the equity, the company is expensive. -2
  • The MRQ is 303.393. Based on the equity, the company is expensive. -2
  • The TTM is 303.393. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD127.151MRQ303.393-176.242
MRQ303.393TTM303.3930.000
TTM303.393YOY0.334+303.059
TTM303.3935Y60.862+242.530
5Y60.86210Y30.628+30.234
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD127.1511.917+125.234
MRQ303.3931.972+301.421
TTM303.3932.210+301.183
YOY0.3342.363-2.029
5Y60.8623.580+57.282
10Y30.6284.206+26.422
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Palatin Technologies Inc.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets17,939
Total Liabilities17,805
Total Stockholder Equity134
 As reported
Total Liabilities 17,805
Total Stockholder Equity+ 134
Total Assets = 17,939

Assets

Total Assets17,939
Total Current Assets16,322
Long-term Assets1,618
Total Current Assets
Cash And Cash Equivalents 7,990
Short-term Investments 2,993
Net Receivables 2,916
Inventory 526
Other Current Assets 1,897
Total Current Assets  (as reported)16,322
Total Current Assets  (calculated)16,322
+/-0
Long-term Assets
Property Plant Equipment 1,561
Long-term Assets Other 57
Long-term Assets  (as reported)1,618
Long-term Assets  (calculated)1,618
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities15,132
Long-term Liabilities2,674
Total Stockholder Equity134
Total Current Liabilities
Short-term Debt 460
Accounts payable 4,304
Other Current Liabilities 10,368
Total Current Liabilities  (as reported)15,132
Total Current Liabilities  (calculated)15,132
+/-0
Long-term Liabilities
Long term Debt Total 46
Capital Lease Obligations Min Short Term Debt590
Other Liabilities 2,083
Long-term Liabilities  (as reported)2,674
Long-term Liabilities  (calculated)2,720
+/- 46
Total Stockholder Equity
Common Stock117
Retained Earnings -415,536
Accumulated Other Comprehensive Income -117
Capital Surplus 415,553
Total Stockholder Equity (as reported)134
Total Stockholder Equity (calculated)17
+/- 117
Other
Capital Stock117
Cash And Equivalents7,990
Cash and Short Term Investments 10,982
Common Stock Shares Outstanding 10,890
Liabilities and Stockholders Equity 17,939
Net Debt -6,939
Net Invested Capital 134
Net Tangible Assets 134
Net Working Capital 1,190
Property Plant and Equipment Gross 4,480
Short Long Term Debt Total 1,051



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-30
> Total Assets 
7,041
14,100
6,500
4,700
8,885
14,244
12,358
22,721
24,379
35,166
40,047
42,781
19,125
13,200
12,389
21,173
5,380
25,074
12,559
29,474
11,052
56,833
39,017
104,735
85,054
67,297
36,071
17,939
17,93936,07167,29785,054104,73539,01756,83311,05229,47412,55925,0745,38021,17312,38913,20019,12542,78140,04735,16624,37922,72112,35814,2448,8854,7006,50014,1007,041
   > Total Current Assets 
6,862
13,100
4,900
2,900
6,508
11,661
8,294
18,830
20,841
26,819
32,187
35,388
13,265
8,820
9,264
19,263
4,737
24,750
12,341
29,196
10,808
56,578
38,514
104,414
83,590
65,907
34,596
16,322
16,32234,59665,90783,590104,41438,51456,57810,80829,19612,34124,7504,73719,2639,2648,82013,26535,38832,18726,81920,84118,8308,29411,6616,5082,9004,90013,1006,862
       Cash And Cash Equivalents 
6,791
12,800
4,500
2,300
3,220
11,456
7,944
14,295
17,947
15,720
28,333
31,448
9,422
4,379
5,405
18,870
3,827
19,168
12,185
27,299
8,003
40,200
38,000
43,510
82,852
60,105
29,939
7,990
7,99029,93960,10582,85243,51038,00040,2008,00327,29912,18519,1683,82718,8705,4054,3799,42231,44828,33315,72017,94714,2957,94411,4563,2202,3004,50012,8006,791
       Short-term Investments 
0
0
0
500
2,156
0
0
4,088
2,465
2,386
2,331
2,324
3,353
3,440
3,462
0
350
5,250
0
0
1,381
250
0
0
0
0
0
2,993
2,993000002501,381005,25035003,4623,4403,3532,3242,3312,3862,4654,088002,156500000
       Net Receivables 
5
100
0
0
953
0
0
0
0
5,441
70
608
6
509
3
131
28
0
0
0
0
15,117
0
60,266
0
1,580
1,780
2,916
2,9161,7801,580060,266015,11700002813135096608705,4410000953001005
       Other Current Assets 
66
200
400
100
180
205
350
448
429
1,889
1,454
1,008
484
493
393
262
882
332
156
225
254
171
325
488
610
1,145
674
1,897
1,8976741,1456104883251712542251563328822623934934841,0081,4541,88942944835020518010040020066
   > Long-term Assets 
179
1,000
1,600
1,800
2,377
2,583
4,064
3,891
3,538
8,347
7,860
7,394
5,860
4,380
3,125
1,910
644
325
218
278
244
255
503
321
1,463
1,390
1,475
1,618
1,6181,4751,3901,4633215032552442782183256441,9103,1254,3805,8607,3947,8608,3473,5383,8914,0642,5832,3771,8001,6001,000179
       Property Plant Equipment 
96
900
1,600
1,500
1,573
1,925
2,416
3,399
2,935
6,464
6,348
6,070
5,128
3,651
2,388
1,305
319
266
161
123
98
198
164
142
1,406
1,333
1,418
1,561
1,5611,4181,3331,406142164198981231612663191,3052,3883,6515,1286,0706,3486,4642,9353,3992,4161,9251,5731,5001,60090096
       Intangible Assets 
0
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000001001000
       Long-term Assets Other 
83
0
-100
300
804
658
1,648
491
603
1,883
1,512
1,323
732
729
737
605
325
58
57
155
146
57
339
180
57
57
57
57
575757571803395714615557583256057377297321,3231,5121,8836034911,648658804300-100083
> Total Liabilities 
4,203
4,300
3,100
4,400
1,980
2,329
3,671
4,065
4,992
25,941
21,748
24,250
12,573
9,886
3,071
2,981
3,550
2,096
2,770
17,270
28,638
61,998
12,052
4,186
4,881
17,645
19,803
17,805
17,80519,80317,6454,8814,18612,05261,99828,63817,2702,7702,0963,5502,9813,0719,88612,57324,25021,74825,9414,9924,0653,6712,3291,9804,4003,1004,3004,203
   > Total Current Liabilities 
2,359
2,700
2,500
2,400
1,980
2,301
3,671
3,988
4,962
13,047
12,445
9,565
4,999
8,670
2,395
2,806
3,457
2,060
2,770
7,356
13,994
54,962
10,763
4,186
3,928
10,512
16,260
15,132
15,13216,26010,5123,9284,18610,76354,96213,9947,3562,7702,0603,4572,8062,3958,6704,9999,56512,44513,0474,9623,9883,6712,3011,9802,4002,5002,7002,359
       Short-term Debt 
1,412
900
900
0
0
397
0
188
33
11
87
217
263
88
20
35
22
20
261
26
5,513
7,839
5,949
333
313
352
472
460
4604723523133335,9497,8395,5132626120223520882632178711331880397009009001,412
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,849
5,485
7,825
5,949
333
0
0
0
0
00003335,9497,8255,4859,8490000000000000000000
       Accounts payable 
214
300
500
1,100
1,012
1,130
1,579
1,345
2,020
4,773
3,093
1,121
635
206
156
497
295
339
261
1,106
714
1,551
2,224
505
716
641
3,158
4,304
4,3043,1586417165052,2241,5517141,1062613392954971562066351,1213,0934,7732,0201,3451,5791,1301,0121,100500300214
       Other Current Liabilities 
733
1,500
1,100
1,300
968
607
1,298
2,048
2,667
4,471
5,270
3,362
2,434
1,381
2,219
2,228
3,103
1,702
1,509
6,223
7,768
10,521
-497,409
500
2,899
3,722
12,630
10,368
10,36812,6303,7222,899500-497,40910,5217,7686,2231,5091,7023,1032,2282,2191,3812,4343,3625,2704,4712,6672,0481,2986079681,3001,1001,500733
   > Long-term Liabilities 
1,844
1,600
600
2,000
1,012
28
2,373
76
30
12,894
9,302
14,685
7,574
1,216
676
175
93
35
1,261
9,914
14,643
7,036
1,289
838
953
7,133
3,543
2,674
2,6743,5437,1339538381,2897,03614,6439,9141,26135931756761,2167,57414,6859,30212,89430762,373281,0122,0006001,6001,844
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
9,823
14,204
6,282
333
0
0
0
152
46
461520003336,28214,2049,82300200000000000000000
       Other Liabilities 
0
0
0
0
0
27
0
0
0
12,875
9,072
14,409
7,452
1,183
662
133
72
36
0
91
439
754
956
0
0
6,233
2,861
2,083
2,0832,8616,2330095675443991036721336621,1837,45214,4099,07212,8750002700000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73
35
0
0
0
0
500
0
0
0
0
0
00000500000035730000000000000000
> Total Stockholder Equity
2,838
9,800
3,400
300
6,905
11,916
8,687
18,657
19,387
9,225
18,300
18,532
6,552
3,313
9,318
18,192
1,831
22,978
9,789
12,204
-17,586
-5,165
26,965
100,549
80,173
49,651
16,268
134
13416,26849,65180,173100,54926,965-5,165-17,58612,2049,78922,9781,83118,1929,3183,3136,55218,53218,3009,22519,38718,6578,68711,9166,9053003,4009,8002,838
   Common Stock
115
0
0
100
79
112
174
430
528
542
709
851
855
867
117
349
349
391
394
571
686
1,605
2,006
2,268
2,293
2,300
93
117
117932,3002,2932,2682,0061,6056865713943913493491178678558517095425284301741127910000115
   Retained Earnings -415,536-387,994-351,795-318,199-295,773-332,046-356,744-343,412-291,699-274,034-260,105-239,243-221,990-209,174-207,382-202,579-188,195-160,444-131,485-117,127-90,809-70,244-54,105-43,506-35,300-23,300-13,400-8,133
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
240,725
282,693
283,428
303,332
325,143
349,975
357,005
394,054
396,079
399,146
404,169
415,553
415,553404,169399,146396,079394,054357,005349,975325,143303,332283,428282,693240,7250000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
10,856
23,400
27,200
36,200
51,239
65,982
78,792
109,085
136,148
144,123
178,089
212,495
208,247
209,712
218,237
251,325
248,970
284,669
285,517
305,538
325,143
349,975
359,344
394,054
396,079
399,146
404,169
397,730
397,730404,169399,146396,079394,054359,344349,975325,143305,538285,517284,669248,970251,325218,237209,712208,247212,495178,089144,123136,148109,08578,79265,98251,23936,20027,20023,40010,856



5.3. Balance Sheets

Currency in USD. All numbers in thousands.